Genetic Diagnostics Firm Gets $40M Shot in the Arm
Invitae Corp. has garnered $40 million in Series E financing to expand its global presence and continue development of multi-gene tests for hereditary disorders.
Read MorePosted by Jenny Lower | Dec 16, 2013 | Uncategorized |
Invitae Corp. has garnered $40 million in Series E financing to expand its global presence and continue development of multi-gene tests for hereditary disorders.
Read MorePosted by Steve Halasey | Dec 16, 2013 | Molecular Diagnostics |
Insight Genetics, a molecular diagnostics company focused on advancing precision medicine in cancer care, has announced the launch of Insight Molecular Labs, a CLIA-certified laboratory offering diagnostic tests that identify cancer biomarkers.
Read MorePosted by Steve Halasey | Nov 26, 2013 | Molecular Diagnostics |
It’s rare when a milestone in medical technology attracts much attention among the nation’s top healthcare brass. But last week, several paused to acknowledge FDA’s clearance of the first high-throughput gene sequencer for clinical lab use.
Read MorePosted by Judy O'Rourke | Oct 22, 2013 | Cancer, Heart Disease, Womens Health |
Labs play a vital role in testing women for heart disease.
Read MorePosted by Judy O'Rourke | Oct 22, 2013 | Molecular Diagnostics |
A single clinical test provides unbiased analysis of the whole genome for challenging cases.
Read More